Patient and Scientific Review Board

Granting access to data from clinical trials sponsored by LEO Pharma shall be made for scientific purposes.

This is why the main task of the Patient and Scientific Review Board is to evaluate requests for data based on the scientific rationale behind the request.

On this site, information about the composition of the Patient and Scientific Review Board, their working procedures, and their previous decisions are made available.

 

The Patient and Scientific Review Board Charter

The Charter explains the procedures and decision making process of the Patient and Scientific Review Board. The Board consists of five members with different professional backgrounds and experience. Three seats are allocated to highly senior scientists, including one statistician, while the two remaining seats are allocated to representatives of patient associations. 

The CV for each board member can be found below.

 

Thomas Bieber, M.D., Ph.D. Professor of Dermatology and Allergy

Christine Janus, CEO of International Alliance of Dermatology Patient Organizations 

Julie Block, CEO of National Eczema Association

 

Senior scientist - in process

Senior scientist - in process

logo
tagline